Appointment of Agent for Service of Process and Undertaking (f-x)
June 10 2022 - 5:14PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM F-X
APPOINTMENT OF AGENT FOR SERVICE OF
PROCESS AND UNDERTAKING
|
A. |
Name of issuer or person
filing (“Filer”): Oncolytics Biotech Inc. |
|
B. |
(1) |
This is (check one): |
|
|
|
|
|
|
x |
An
original filing for the Filer. |
|
|
|
|
|
|
¨ |
An amended filing for the Filer. |
|
|
(2) |
Check the following box if you are filing the Form F-X in paper in accordance
with Regulation S-T Rule 101(b)(9) ¨ |
|
C. |
Identify the filing in
conjunction with which this form is being filed: |
|
|
Name of registrant: |
Oncolytics Biotech Inc. |
|
|
Form type: |
Registration Statement on Form F-10 |
|
|
File number (if known): |
333-265510
|
|
|
Filed by: |
Oncolytics Biotech Inc. |
|
|
Date filed (if filed concurrently, so indicate): |
June 9, 2022 (filed concurrently) |
| D. | The Filer is incorporated or organized under the laws of Alberta, Canada, and has its principal place of business at Suite
804, 322 11th Avenue SW, Calgary, Alberta, Canada, T2R 0C5, telephone number (403) 670-7377. |
| E. | Filer designates and appoints Registered Agent Solutions, Inc. (“Agent”), located at 3400 Capitol Boulevard
SE, Suite 101, Tumwater, Washington 98501, telephone number (800) 547-7007, as the agent of the Filer upon whom may be served
any process, pleadings, subpoenas, or other papers in: |
| (a) | any investigation or administrative proceeding conducted by the Commission; and |
| (b) | any civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate
court in any place subject to the jurisdiction of any state or of the United States, or of any of its territories or possessions or of
the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns any offering
made or purported to be made in connection with the securities registered or qualified by the Filer on Form F-10 on June 9, 2022 or any
purchases or sales of any security in connection therewith. The Filer stipulates and agrees that any such civil suit or action or administrative
proceeding may be commenced by the service of process upon, and that the service of an administrative subpoena shall be effected by service
upon such agent for service of process, and that the service as aforesaid shall be taken and held in all courts and administrative tribunals
to be valid and binding as if personal service thereof had been made. |
| F. | The Filer stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges
the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the
date the issuer of the securities to which the Form F-10 relates has ceased reporting under the U.S. Securities Exchange Act of 1934,
as amended. |
|
|
The Filer further undertakes to advise
the Securities and Exchange Commission promptly of any change to the Agent’s name or address during the applicable period by amendment
of this form, referencing the file number of the relevant form in conjunction with which the amendment is being filed. |
| G. | The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission
staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the Form F-10; the securities
to which the Form F-10 relates; and the transactions in such securities. |
SIGNATURES
The Filer certifies that it has duly caused this
power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereunto duly authorized, on June
9, 2022.
|
ONCOLYTICS BIOTECH INC. |
|
|
|
|
|
|
By: |
/s/ Kirk J. Look |
|
|
Name: |
Kirk J. Look |
|
|
Title: |
Chief Financial Officer |
|
This statement has been signed by the following
person in the capacity indicated June 9, 2022.
|
Registered Agent Solutions, Inc. |
|
|
(Agent for Service) |
|
|
|
|
|
|
By: |
/s/ Fanny Sparling |
|
|
Name: |
Fanny Sparling |
|
|
Title: |
Assistant Secretary |
|
Oncolytics Biotech (NASDAQ:ONCY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Oncolytics Biotech (NASDAQ:ONCY)
Historical Stock Chart
From Oct 2023 to Oct 2024